ConvaTec Group’s (CTEC) “Buy” Rating Reaffirmed at Jefferies Financial Group

ConvaTec Group (LON:CTEC)‘s stock had its “buy” rating reiterated by research analysts at Jefferies Financial Group in a report released on Monday,Digital Look reports. They currently have a GBX 300 target price on the stock. Jefferies Financial Group’s price objective suggests a potential upside of 49.25% from the stock’s previous close.

CTEC has been the subject of a number of other reports. JPMorgan Chase & Co. cut their price target on ConvaTec Group from GBX 307 to GBX 294 and set an “overweight” rating for the company in a research note on Friday, May 22nd. Citigroup cut their price target on ConvaTec Group from GBX 250 to GBX 230 and set a “neutral” rating for the company in a research note on Monday, May 18th. UBS Group reaffirmed a “buy” rating and set a GBX 375 price target on shares of ConvaTec Group in a research note on Monday, May 18th. Stifel Nicolaus reaffirmed a “buy” rating and set a GBX 315 price target on shares of ConvaTec Group in a research note on Wednesday, March 11th. Finally, Berenberg Bank reaffirmed a “buy” rating and set a GBX 340 price target on shares of ConvaTec Group in a research note on Tuesday, April 21st. Eight analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 306.

ConvaTec Group Stock Down 2.4%

CTEC opened at GBX 201 on Monday. ConvaTec Group has a fifty-two week low of GBX 193 and a fifty-two week high of GBX 295.76. The business has a 50-day moving average of GBX 214.96 and a 200-day moving average of GBX 227.76. The company has a debt-to-equity ratio of 106.19, a current ratio of 1.53 and a quick ratio of 0.96. The company has a market capitalization of £3.93 billion, a PE ratio of 23.37, a price-to-earnings-growth ratio of 0.93 and a beta of 0.76.

Insider Buying and Selling at ConvaTec Group

In related news, insider Jonny Mason sold 291,149 shares of the firm’s stock in a transaction that occurred on Monday, March 16th. The stock was sold at an average price of GBX 234, for a total value of £681,288.66. Insiders own 0.98% of the company’s stock.

About ConvaTec Group

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.